Asia Pacific fluoroscopy systems market will grow by 5.8% annually with a total addressable market cap of $17,449.2 million over 2023-2032, driven by the increasing prevalence in incidence of cardiovascular diseases and other disorders, the rising awareness for fluoroscopic equipment, superior visualization properties of fluoroscopic imaging, and growing geriatric population, and the technological advancement due to the increasing R&D investment. Highlighted with 29 tables and 43 figures,...
Global surgical instrument tracking systems market will reach $740.5 million by 2031, growing by 13.1% annually over 2021-2031, driven by the growing geriatric population with chronic ailments, increasing need for ensuring better inventory and asset management practices, implementation of unique device identification (UDI) regulations by the FDA, rising number of surgical procedures, and the availability of technologically advanced products. Highlighted with 82 tables and 72 figures, thi...
North America surgical instrument tracking systems market is projected to grow by 12.3% annually in the forecast period and reach $422.7 million by 2031, driven by the growing geriatric population with chronic ailments, increasing need for ensuring better inventory and asset management practices, implementation of unique device identification (UDI) regulations by the FDA, rising number of surgical procedures, and the availability of technologically advanced products. Highlighted with 22 ...
Europe surgical instrument tracking systems market was valued at $46.3 million in 2021 and will grow by 13.9% annually over 2021-2031, driven by the growing geriatric population with chronic ailments, increasing need for ensuring better inventory and asset management practices, implementation of unique device identification (UDI) regulations by the FDA, rising number of surgical procedures, and the availability of technologically advanced products. Highlighted with 32 tables and 40 figur...
Asia Pacific medicated feed additives market will grow by 15.5% annually with a total addressable market cap of $738.0 million over 2022-2031, driven by the growing geriatric population with chronic ailments, increasing need for ensuring better inventory and asset management practices, implementation of unique device identification (UDI) regulations by the FDA, rising number of surgical procedures, and the availability of technologically advanced products. Highlighted with 29 tables and ...
Global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 92 tables and 79 figure...
North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with...
Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 42 tables and 37 f...
Asia Pacific transcriptomics market will grow by 13.1% annually with a total addressable market cap of $ 29,787.1 million over 2022-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted w...
Global upper limb prosthetics market will reach $ 981.8 million by 2031, growing by 4.8% annually over 2021-2031, driven by the rising prevalence of bone infection in the elderly population, the increasing incidence of accidents and trauma, the growing prevalence of diabetes, and the technological advancements in prosthetics along with more R&D investment in the industry. Highlighted with 80 tables and 76 figures, this 149-page report “Global Upper Limb Prosthetics Market 2021-2031 by ...
